-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DnprTSlbhvah/A3AhCC/Ei3GW7PGpcnrTK3n2NMgmC/eCIgRwJ1RY1rX0S/tS09X EeNttWvFkKhuXCzhC5qCgw== 0000947871-07-001435.txt : 20071114 0000947871-07-001435.hdr.sgml : 20071114 20071114163922 ACCESSION NUMBER: 0000947871-07-001435 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20071114 DATE AS OF CHANGE: 20071114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MERRILL LYNCH PIERCE FENNER & SMITH INC CENTRAL INDEX KEY: 0000728612 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-92161 FILM NUMBER: 071245565 BUSINESS ADDRESS: STREET 1: 4 WORLD FINANCIAL CENTER STREET 2: NORTH TOWER CITY: NEW YORK STATE: NY ZIP: 10080 BUSINESS PHONE: 2126702273 MAIL ADDRESS: STREET 1: 4 WORLD FINANCIAL CENTER STREET 2: NORTH TOWER CITY: NEW YORK STATE: NY ZIP: 10080 424B3 1 f424b3_110807-pharmaceutical.htm

 

PROSPECTUS SUPPLEMENT

        REGISTRATION NO. 333-92161

(To Prospectus dated August 15, 2007)

333-95805

 

        Filed Pursuant to Rule 424(b)(3)

 

 

 

 

 

1,000,000,000 Depositary Receipts

Pharmaceutical HOLDRS (SM) Trust

 

This prospectus supplement supplements information contained in the prospectus dated August 15, 2007 relating to the sale of up to 1,000,000,000 depositary receipts by the Pharmaceutical HOLDRS (SM) Trust.

The share amounts specified in the table in the “Highlights of Pharmaceutical HOLDRS” section of the base prospectus shall be replaced with the following:

 

Name of Company

Ticker

Share
Amounts

Primary
Trading
Market

Abbott Laboratories

ABT

14

NYSE

Advanced Medical Optics, Inc.

EYE

0.2222

NYSE

Allergan, Inc.

AGN

2

NYSE

Biovail Corporation

BVF

4

NYSE

Bristol-Myers Squibb Company

BMY

18

NYSE

Eli Lilly & Company

LLY

10

NYSE

Forest Laboratories, Inc.

FRX

4

NYSE

Hospira, Inc.

HSP

1.4

NYSE

Johnson & Johnson

JNJ

26

NYSE

King Pharmaceuticals, Inc.

KG

4.25

NYSE

Medco Health Solutions

MHS

2.6532

NYSE

Merck & Co., Inc.

MRK

22

NYSE

Mylan, Inc.(1)

MYL

2.25

NYSE

Pfizer Inc.

PFE

58

NYSE

Schering-Plough Corporation

SGP

14

NYSE

Valeant Pharmaceuticals

VRX

1

NYSE

Watson Pharmaceuticals, Inc.

WPI

1

NYSE

Wyeth

WYE

12

NYSE

Zimmer Holdings, Inc.

ZMH

1.8

NYSE

 

(1)

Effective October 1, 2007, Mylan Laboratories, Inc. (NYSE ticker “MYL”), an underlying constituent of the Pharmaceuticals HOLDRS Trust, changed its name to Mylan, Inc.

 

The share amounts listed in the table above reflect all previous stock splits, dividends and business combination transactions.

 

The date of this prospectus supplement is September 30, 2007.

 

 

 

 GRAPHIC 2 img1.gif GRAPHIC begin 644 img1.gif M1TE&.#EA00%9`'<``"'_"TU33T9&24-%.2XP#0````%S4D="`*[.'.D`(?\+ M35-/1D9)0T4Y+C`8````#&US3U!-4T]&1DE#13DN,!.;*91D`"P`````00%9 M`(0P?[\O?[\P?\`P@,"_O[^PL+"OKZ^@H*#?W]_/S\_`P,#0T-#OD`#@CP#@ MD`#P\/#O[^_@X.#___\!`@,!`@,!`@,!`@,!`@,!`@,!`@,!`@,!`@,!`@,! M`@,!`@,!`@,%_Z`DCF1IGFBJKFSKOG`LSW1MWWBN[WSO_\"@<$@L&H_(I'+) M;#J?T*AT2JU:K]BL=LOM>K_@L'A,+IO/Z+1ZS6Z[W_"X?$ZOV^_XO'[/[_O_ M3`\2@H(DA8.`B8J+C(U(AX:.DH``E9:5DYF)A0`"`0.=GZ&@GH2:IW>7`)&$ MJJN0J+%KHXBFA`^XN*2?N::ROV.7*K:YE[[`R%^BK+7-Q+NYS?K::&X$+CLD@ST]#/U]EKIT2/X#$/^`@K,EV.@ M08$X#BHD@4^"/8)1&C!PP*#!#(D4+6;Q!(I4Y=Q%3C;&7 M;U](H8&D9G%8M%+6A6&/EH,U1NT6@CI*RV&*(X!W?@6!%6E21DKCCF'B@"CSOE0#>#@=NAUW_"PF>T*"#XJV!UH1N;;:";K8@ MLH,HGD#@H8<:(C+<48P8%?0!"!A\%]M-]1];WPDFTM(BE68Q2Z M"".1K:5`XR#6":A*5U264R1A/X87X9!DQMD=D5^LN(*>@[B#(P3.X`#E`!]& MP(\(7Y6HFJ):\GG"D6&J9$1\7KQYG7D#IZ+H*F6:0S+ZJ[O? MO8IBPQ#G2X#F2I0IU++,,\L?TNL"R>.`D`""BQP\6-*^R:SKC0[%&F8.U_=95U@ M5J0?N"5`NG7/6.B[HRI,.UTK##=7$L$""U@,ZLX_0T&YHJ)ZC#?JN5=/N>\VX&BY\\`&XGD#< MTOZN/`VY-W^S`DU/[57ORUL/+'I0*`+T%3"T>HZ->&E@G@7`T M<``BX%#\?//`52Q#`KM8'WLPJ+0'1E"`$$27""C(04<(0GS0*H`!"$``UR$O M5'ZPGPR%P3],0*N&JX`?_O;GOQZVSX?Z^Z$))1"!ZX%0A08H`/GBMBX8(FH/ M&]3@!#E(02AIT(I&M&`(`U""3DQ1BE*$C%8&)0&E3V0"%T5LVP$,L,8DME!Z M1%%@'*8COQ_>#(=VK-_[U.?#'=K/?WQD!"$@$+,$$`")!D@B`5L8.RJ![Y%" M@$?`*!8ZQ1T*DIC -----END PRIVACY-ENHANCED MESSAGE-----